CY1113185T1 - Μεθοδοι συνενωσης αποδεκτη πεπτιδιου - Google Patents
Μεθοδοι συνενωσης αποδεκτη πεπτιδιουInfo
- Publication number
- CY1113185T1 CY1113185T1 CY20121100522T CY121100522T CY1113185T1 CY 1113185 T1 CY1113185 T1 CY 1113185T1 CY 20121100522 T CY20121100522 T CY 20121100522T CY 121100522 T CY121100522 T CY 121100522T CY 1113185 T1 CY1113185 T1 CY 1113185T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methods
- acceptance
- peptide
- accepted
- accepted peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1062—Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
Abstract
Στο παρόν κείμενο περιγράφονται μέθοδοι και αντιδραστήρια για τη συνένωση αποδέκτη πεπτιδίου με RΝΑ, καθώς και προϊόντα του RΝΑ-αποδέκτη πεπτιδίου.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14583499P | 1999-07-27 | 1999-07-27 | |
EP07005917A EP1870417B9 (en) | 1999-07-27 | 2000-07-19 | Peptide acceptor ligation methods |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1113185T1 true CY1113185T1 (el) | 2016-04-13 |
Family
ID=22514769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121100522T CY1113185T1 (el) | 1999-07-27 | 2012-06-08 | Μεθοδοι συνενωσης αποδεκτη πεπτιδιου |
Country Status (16)
Country | Link |
---|---|
US (3) | US6429300B1 (el) |
EP (2) | EP1196637B1 (el) |
JP (2) | JP4766808B2 (el) |
KR (1) | KR20020033743A (el) |
AT (2) | ATE360706T1 (el) |
AU (2) | AU781783B2 (el) |
CA (2) | CA2693274C (el) |
CY (1) | CY1113185T1 (el) |
DE (1) | DE60034566T2 (el) |
DK (2) | DK1196637T3 (el) |
ES (2) | ES2284508T3 (el) |
HK (2) | HK1045334A1 (el) |
IL (1) | IL147037A0 (el) |
NO (1) | NO20020348D0 (el) |
PT (2) | PT1196637E (el) |
WO (1) | WO2001007657A1 (el) |
Families Citing this family (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU781783B2 (en) * | 1999-07-27 | 2005-06-16 | Bristol-Myers Squibb Company | Peptide acceptor ligation methods |
DE60033851T2 (de) | 2000-01-11 | 2007-11-08 | Nanogen Recognomics Gmbh | Biomoleküle mit multiplen anbindungsabschnitten zur bindung an eine substratoberfläche |
EP1268769A2 (de) * | 2000-03-31 | 2003-01-02 | Memorec Stoffel GmbH Medizinisch-Molekulare Entwicklung | Verfahren zur extraktion von nukleinsäuren |
US20040229271A1 (en) | 2000-05-19 | 2004-11-18 | Williams Richard B. | Compositions and methods for the identification and selection of nucleic acids and polypeptides |
US6962781B1 (en) * | 2000-05-19 | 2005-11-08 | Proteonova, Inc. | In vitro evolution of nucleic acids and encoded polypeptide |
US7410761B2 (en) * | 2000-05-19 | 2008-08-12 | Proteonova, Inc. | System for rapid identification and selection of nucleic acids and polypeptides, and method thereof |
DE60136715D1 (de) * | 2000-08-11 | 2009-01-08 | Nanogen Recognomics Gmbh | Hydrazidbausteine und hydratin-modifizierte biomoleküle |
US7129229B2 (en) | 2000-08-11 | 2006-10-31 | Nanogen Recognomics Gmbh | Hydrazide building blocks and hydrazide modified biomolecules |
JP4963142B2 (ja) * | 2000-12-14 | 2012-06-27 | 学校法人慶應義塾 | 遺伝子型と表現型の対応付け分子とその構成要素、および対応付け分子の製造方法と利用方法 |
US20060234231A1 (en) * | 2001-06-20 | 2006-10-19 | Nuevolution A/S | Microarrays displaying encoded molecules |
EP1401850A1 (en) | 2001-06-20 | 2004-03-31 | Nuevolution A/S | Nucleoside derivatives for library preparation |
US6893822B2 (en) | 2001-07-19 | 2005-05-17 | Nanogen Recognomics Gmbh | Enzymatic modification of a nucleic acid-synthetic binding unit conjugate |
WO2003012146A1 (en) * | 2001-07-31 | 2003-02-13 | Phylos, Inc. | Modular assembly of nucleic acid-protein fusion multimers |
DE10147074A1 (de) * | 2001-09-25 | 2003-05-08 | Beru Ag | Verfahren zum Betreiben einer aus mehreren Heizelementen bestehenden mehrstufigen elektrischen Heizung |
AU2002356984A1 (en) * | 2001-11-16 | 2003-06-10 | Proteonova, Inc. | Selection and evolution of nucleic acids and polypeptides |
WO2003045975A2 (en) * | 2001-11-27 | 2003-06-05 | Compound Therapeutics, Inc. | Solid-phase immobilization of proteins and peptides |
DE20200926U1 (de) * | 2002-01-23 | 2002-04-18 | Hegenscheidt Mfd Gmbh & Co Kg | Festwalzgerät einer Festwalzmaschine für Kurbelwellen |
US20060166197A1 (en) * | 2002-03-15 | 2006-07-27 | Gouliaev Alex H | Building block capable of transferring a functional entity |
AU2003253069A1 (en) * | 2002-03-15 | 2003-09-29 | Nuevolution A/S | A building block forming a c-c bond upon reaction |
WO2003078446A2 (en) * | 2002-03-15 | 2003-09-25 | Nuevolution A/S | A building block forming a c-c or a c-hetero atom bond upon reaction |
WO2003078625A2 (en) * | 2002-03-15 | 2003-09-25 | Nuevolution A/S | An improved method for synthesising templated molecules |
AU2003247266A1 (en) | 2002-08-01 | 2004-02-23 | Nuevolution A/S | Multi-step synthesis of templated molecules |
US20040058886A1 (en) * | 2002-08-08 | 2004-03-25 | Dharmacon, Inc. | Short interfering RNAs having a hairpin structure containing a non-nucleotide loop |
CN106337046B (zh) | 2002-10-30 | 2021-03-23 | 纽韦卢森公司 | 合成双功能复合物的方法 |
DE60330406D1 (de) | 2002-12-19 | 2010-01-14 | Nuevolution As | Durch quasizufallsstrukturen und funktionen geführte synthesemethode |
WO2004074429A2 (en) | 2003-02-21 | 2004-09-02 | Nuevolution A/S | Method for producing second-generation library |
EP1597394A2 (en) * | 2003-02-21 | 2005-11-23 | Nuevolution A/S | A method for obtaining structural information about an encoded molecule |
EP2236606B1 (en) * | 2003-03-20 | 2013-11-06 | Nuevolution A/S | Ligational encoding of small molecules |
WO2004110964A2 (en) * | 2003-06-16 | 2004-12-23 | Nuevolution A/S | Encoded molecules by translation (emt) |
US20050095627A1 (en) * | 2003-09-03 | 2005-05-05 | The Salk Institute For Biological Studies | Multiple antigen detection assays and reagents |
DE602004023960D1 (de) | 2003-09-18 | 2009-12-17 | Nuevolution As | Methode zur Gewinnung struktureller Informationen kodierter Moleküle und zur Selektion von Verbindungen |
KR101320905B1 (ko) * | 2003-11-20 | 2013-11-06 | 사노피 파스퇴르 인크 | 백일해 독소의 정제방법 및 이에 유용한 펩타이드 |
EP1711196A4 (en) | 2003-12-05 | 2011-09-14 | Bristol Myers Squibb Co | INHIBITORS OF TYPE-2 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS |
CA2548465A1 (en) * | 2003-12-12 | 2005-08-11 | Proteonova, Inc. | System and methods for nucleic acid and polypeptide selection |
US20090239211A1 (en) * | 2004-02-17 | 2009-09-24 | Nuevolution A/S | Method For Enrichment Involving Elimination By Mismatch Hybridisation |
ATE447020T1 (de) * | 2004-03-22 | 2009-11-15 | Nuevolution As | Ligationscodierung unter verwendung von oligonukleotidbausteinen |
CA2467321A1 (en) * | 2004-05-14 | 2005-11-14 | Paul J. Santerre | Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
US8445413B2 (en) | 2004-10-15 | 2013-05-21 | National Institute Of Advanced Industrial Science And Technology | Linker for constructing mRNA-puromycin-protein conjugate |
EP2261257B1 (en) | 2005-01-12 | 2018-07-11 | Proteonova, Inc. | Method for making targeted therapeutic agents |
US10206998B2 (en) | 2005-01-12 | 2019-02-19 | Proteonova, Inc. | Modular targeted therapeutic agents and methods of making same |
AU2006315347A1 (en) | 2005-11-16 | 2007-05-24 | Ambrx, Inc. | Methods and compositions comprising non-natural amino acids |
ES2897529T3 (es) | 2005-12-01 | 2022-03-01 | Nuevolution As | Métodos de codificación enzimática para la síntesis eficiente de bibliotecas grandes |
US7749957B2 (en) | 2006-04-06 | 2010-07-06 | E.I. Du Pont De Nemours And Company | Clay-binding peptides and methods of use |
EP2727936B1 (en) | 2006-11-22 | 2016-09-07 | Bristol-Myers Squibb Company | Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR |
EP2118344B1 (en) | 2007-02-12 | 2014-07-23 | Proteonova, Inc. | GENERATION OF LIBRARY OF SOLUBLE RANDOM POLYPEPTIDES LINKED TO mRNA |
US7678883B2 (en) * | 2007-07-25 | 2010-03-16 | E.I. Du Pont De Nemours And Company | Solubility tags for the expression and purification of bioactive peptides |
US7951559B2 (en) * | 2007-07-25 | 2011-05-31 | E.I. Du Pont De Nemours And Company | Recombinant peptide production using a cross-linkable solubility tag |
US7829311B2 (en) | 2007-07-25 | 2010-11-09 | E.I. Du Pont De Nemours And Company | Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate |
US7794963B2 (en) | 2007-11-02 | 2010-09-14 | E.I. Du Pont De Nemours And Company | Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins |
US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
KR20190045414A (ko) | 2007-11-30 | 2019-05-02 | 애브비 바이오테크놀로지 리미티드 | 단백질 제형 및 이의 제조방법 |
KR20100128291A (ko) | 2008-02-14 | 2010-12-07 | 브리스톨-마이어스 스큅 컴퍼니 | Egfr에 결합하는 조작된 단백질을 기초로 하는 표적화된 치료제 |
EP2283132B1 (en) * | 2008-05-02 | 2016-10-26 | Epicentre Technologies Corporation | Selective 5' ligation tagging of rna |
US9296810B2 (en) | 2008-05-02 | 2016-03-29 | Novartis Ag | Fibronectin-based binding molecules and uses thereof |
WO2009142773A2 (en) | 2008-05-22 | 2009-11-26 | Bristol-Myers Squibb Company | Multivalent fibronectin based scaffold domain proteins |
ES2752025T3 (es) | 2008-07-25 | 2020-04-02 | Wagner Richard W | Métodos de cribado de proteínas |
MX2011003381A (es) * | 2008-09-30 | 2011-04-21 | Abbott Lab | Metodo mejorado para despliegue de arn. |
TWI496582B (zh) | 2008-11-24 | 2015-08-21 | 必治妥美雅史谷比公司 | 雙重專一性之egfr/igfir結合分子 |
US20100158822A1 (en) * | 2008-12-18 | 2010-06-24 | E .I. Du Pont De Nemours And Company | Peptides that bind to silica-coated particles |
US20100158837A1 (en) | 2008-12-18 | 2010-06-24 | E. I. Du Pont De Nemours And Company | Iron oxide-binding peptides |
US8287845B2 (en) * | 2008-12-18 | 2012-10-16 | E I Du Pont De Nemours And Company | Hair-binding peptides |
US20100158846A1 (en) * | 2008-12-18 | 2010-06-24 | E. I. Du Pont De Nemours And Company | Hair-binding peptides |
US20100247590A1 (en) * | 2009-03-30 | 2010-09-30 | Johnson & Johnson | Peptide-Based Systems For Delivery Of Cosmetic Agents |
US8481678B2 (en) | 2009-03-30 | 2013-07-09 | E I Du Pont De Nemours And Company | Peptide-based tooth whitening reagents |
JP5733784B2 (ja) * | 2009-09-24 | 2015-06-10 | 国立大学法人埼玉大学 | cDNA/mRNA−タンパク質連結体の効率的合成法 |
WO2011051327A2 (en) | 2009-10-30 | 2011-05-05 | Novartis Ag | Small antibody-like single chain proteins |
WO2011051466A1 (en) | 2009-11-02 | 2011-05-05 | Novartis Ag | Anti-idiotypic fibronectin-based binding molecules and uses thereof |
WO2011092233A1 (en) | 2010-01-29 | 2011-08-04 | Novartis Ag | Yeast mating to produce high-affinity combinations of fibronectin-based binders |
JP2013519869A (ja) | 2010-02-10 | 2013-05-30 | ノバルティス アーゲー | 筋肉成長のための方法および化合物 |
WO2011126370A1 (en) * | 2010-04-09 | 2011-10-13 | Universiteit Utrecht Holding B.V. | Recombinant multimeric influenza proteins |
WO2011127933A1 (en) | 2010-04-16 | 2011-10-20 | Nuevolution A/S | Bi-functional complexes and methods for making and using such complexes |
TW201138808A (en) | 2010-05-03 | 2011-11-16 | Bristol Myers Squibb Co | Serum albumin binding molecules |
WO2011150133A2 (en) | 2010-05-26 | 2011-12-01 | Bristol-Myers Squibb Company | Fibronectin based scaffold proteins having improved stability |
MX345300B (es) | 2010-07-30 | 2017-01-24 | Novartis Ag * | Moléculas andamio de fibronectina y bibliotecas de las mismas. |
DE102010056289A1 (de) | 2010-12-24 | 2012-06-28 | Geneart Ag | Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken |
ES2926988T3 (es) | 2011-03-15 | 2022-10-31 | X Body Inc | Métodos de cribado de anticuerpos |
SI3418380T1 (sl) | 2011-04-28 | 2022-10-28 | The Board Of Trustees Of The Leland Stanford Junior University | Identifikacija polinukleotidov, povezanih z vzorcem |
WO2013019794A1 (en) | 2011-08-01 | 2013-02-07 | The General Hospital Corporation | Protein and peptide libraries |
RS60828B1 (sr) | 2011-10-11 | 2020-10-30 | Viela Bio Inc | Cd40l-specifične konstrukcije izvedene iz tn3 i metode za njihovu primenu |
EP2788379B1 (en) | 2011-12-05 | 2020-02-05 | X-Body, Inc. | Pdgf receptor beta binding polypeptides |
EP2975121A4 (en) * | 2013-03-13 | 2016-07-20 | Univ Tokyo | NUCLEIC ACID BINDING SEQUENCE |
US10370651B2 (en) | 2013-06-28 | 2019-08-06 | X-Body, Inc. | Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes |
CN103382579B (zh) * | 2013-07-06 | 2015-10-21 | 中国科学院成都生物研究所 | 一种体外筛选多肽的方法 |
EP3049811B1 (en) | 2013-09-23 | 2020-09-09 | X-Body, Inc. | Methods and compositions for generation of binding agents against cell surface antigens |
EP3090049B1 (en) * | 2013-12-31 | 2017-10-18 | F. Hoffmann-La Roche AG | Enrichment of full-length oligonucleotides via transcription/translation-mediated purification |
WO2015120058A2 (en) | 2014-02-05 | 2015-08-13 | Molecular Templates, Inc. | Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity |
KR20220162886A (ko) | 2014-03-20 | 2022-12-08 | 브리스톨-마이어스 스큅 컴퍼니 | 혈청 알부민-결합 피브로넥틴 유형 iii 도메인 |
JP6478392B2 (ja) * | 2014-12-26 | 2019-03-06 | 国立研究開発法人産業技術総合研究所 | 核酸リンカー |
CA2977675A1 (en) | 2015-03-12 | 2016-09-15 | Medimmune, Llc | Method of purifying albumin-fusion proteins |
KR20180056701A (ko) | 2015-09-23 | 2018-05-29 | 브리스톨-마이어스 스큅 컴퍼니 | 패스트-오프 레이트 혈청 알부민 결합 피브로넥틴 유형 iii 도메인 |
KR102379048B1 (ko) | 2016-05-02 | 2022-03-28 | 엔코디아, 인코포레이티드 | 암호화 핵산을 사용한 거대분자 분석 |
CN109790565A (zh) * | 2016-06-15 | 2019-05-21 | 基因捕获公司 | 包含茎-环捕获分子的组合物、方法和装置 |
WO2018005559A1 (en) | 2016-06-27 | 2018-01-04 | Juno Therapeutics, Inc. | Method of identifying peptide epitopes, molecules that bind such epitopes and related uses |
MA45491A (fr) | 2016-06-27 | 2019-05-01 | Juno Therapeutics Inc | Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés |
SG11201908817WA (en) | 2017-03-21 | 2019-10-30 | Fujifilm Corp | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound |
SG11202003924YA (en) * | 2017-10-31 | 2020-05-28 | Encodia Inc | Kits for analysis using nucleic acid encoding and/or label |
RU2020112854A (ru) | 2017-11-30 | 2021-12-30 | Арракис Терапьютикс, Инк. | Фотозонды, связывающие нуклеиновые кислоты, и способы их применения |
CA3087898A1 (en) | 2018-02-02 | 2019-08-08 | Ripple Therapeutics Corporation | Glass formulations comprising steroid dimers and uses thereof |
TWI830718B (zh) * | 2018-02-09 | 2024-02-01 | 日商住友化學股份有限公司 | 核酸分子之製造方法 |
CN111971396A (zh) * | 2018-03-30 | 2020-11-20 | 住友化学株式会社 | 单链rna的制造方法 |
WO2019236644A1 (en) * | 2018-06-05 | 2019-12-12 | Arrakis Therapeutics, Inc. | Encoded libraries and methods of use for screening nucleic acid targets |
CA3176134A1 (en) | 2020-05-01 | 2021-11-04 | Ripple Therapeutics Corporation | Heterodimer compositions and methods for the treatment of ocular disorders |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5391723A (en) * | 1989-05-31 | 1995-02-21 | Neorx Corporation | Oligonucleotide conjugates |
US5843701A (en) * | 1990-08-02 | 1998-12-01 | Nexstar Pharmaceticals, Inc. | Systematic polypeptide evolution by reverse translation |
AU8124694A (en) * | 1993-10-29 | 1995-05-22 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
DE19646372C1 (de) * | 1995-11-11 | 1997-06-19 | Evotec Biosystems Gmbh | Genotyp und Phänotyp koppelnde Verbindung |
EP0862656B1 (en) * | 1995-11-21 | 2001-03-07 | Yale University | Unimolecular segment amplification and detection |
US6117635A (en) * | 1996-07-16 | 2000-09-12 | Intergen Company | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
US5842701A (en) * | 1996-10-08 | 1998-12-01 | Smith International, Inc. | Dual functioning seal for rock bits |
CA2268353A1 (en) | 1996-10-10 | 1998-04-16 | Henrik Garoff | Alphavirus-retrovirus vectors |
DE69730157T2 (de) * | 1996-10-17 | 2005-07-28 | Mitsubishi Chemical Corp. | Molekül, welches genotyp und phänotyp zusammenführt und dessen anwendungen |
US6261804B1 (en) * | 1997-01-21 | 2001-07-17 | The General Hospital Corporation | Selection of proteins using RNA-protein fusions |
DE69835143T2 (de) * | 1997-01-21 | 2007-06-06 | The General Hospital Corp., Boston | Selektion von proteinen mittels rns-protein fusionen |
US5935791A (en) * | 1997-09-23 | 1999-08-10 | Becton, Dickinson And Company | Detection of nucleic acids by fluorescence quenching |
PT1052292E (pt) * | 1997-12-22 | 2003-06-30 | Genset Sa | Gene associado ao cancro da prostata |
US5985575A (en) * | 1998-05-20 | 1999-11-16 | Wisconsin Alumni Research Foundation | Tethered function assay for protein function |
AU781783B2 (en) * | 1999-07-27 | 2005-06-16 | Bristol-Myers Squibb Company | Peptide acceptor ligation methods |
WO2001016352A1 (en) * | 1999-08-27 | 2001-03-08 | Phylos, Inc. | Methods for encoding and sorting in vitro translated proteins |
-
2000
- 2000-07-19 AU AU61112/00A patent/AU781783B2/en not_active Expired
- 2000-07-19 CA CA2693274A patent/CA2693274C/en not_active Expired - Lifetime
- 2000-07-19 CA CA2377468A patent/CA2377468C/en not_active Expired - Lifetime
- 2000-07-19 EP EP00947524A patent/EP1196637B1/en not_active Expired - Lifetime
- 2000-07-19 KR KR1020027001058A patent/KR20020033743A/ko not_active Application Discontinuation
- 2000-07-19 PT PT00947524T patent/PT1196637E/pt unknown
- 2000-07-19 WO PCT/US2000/019653 patent/WO2001007657A1/en active IP Right Grant
- 2000-07-19 JP JP2001512922A patent/JP4766808B2/ja not_active Expired - Lifetime
- 2000-07-19 AT AT00947524T patent/ATE360706T1/de active
- 2000-07-19 DK DK00947524T patent/DK1196637T3/da active
- 2000-07-19 DE DE60034566T patent/DE60034566T2/de not_active Expired - Lifetime
- 2000-07-19 ES ES00947524T patent/ES2284508T3/es not_active Expired - Lifetime
- 2000-07-19 PT PT07005917T patent/PT1870417E/pt unknown
- 2000-07-19 US US09/619,103 patent/US6429300B1/en not_active Expired - Lifetime
- 2000-07-19 IL IL14703700A patent/IL147037A0/xx unknown
- 2000-07-19 AT AT07005917T patent/ATE551352T1/de active
- 2000-07-19 EP EP07005917A patent/EP1870417B9/en not_active Expired - Lifetime
- 2000-07-19 DK DK07005917.5T patent/DK1870417T3/da active
- 2000-07-19 ES ES07005917T patent/ES2383332T3/es not_active Expired - Lifetime
-
2002
- 2002-01-23 NO NO20020348A patent/NO20020348D0/no not_active Application Discontinuation
- 2002-07-30 US US10/208,357 patent/US7078197B2/en not_active Expired - Lifetime
- 2002-09-13 HK HK02106728.4A patent/HK1045334A1/zh unknown
-
2005
- 2005-09-15 AU AU2005211548A patent/AU2005211548B2/en not_active Expired
-
2006
- 2006-07-10 US US11/483,495 patent/US7790421B2/en not_active Expired - Fee Related
-
2008
- 2008-06-26 HK HK08107091.5A patent/HK1112007A1/xx not_active IP Right Cessation
-
2010
- 2010-08-24 JP JP2010186725A patent/JP5512463B2/ja not_active Expired - Lifetime
-
2012
- 2012-06-08 CY CY20121100522T patent/CY1113185T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1113185T1 (el) | Μεθοδοι συνενωσης αποδεκτη πεπτιδιου | |
DE60010098D1 (de) | 28-epirapaloge | |
WO2003012119A3 (en) | Nucleic acid amplification method | |
IL130885A (en) | Hybridisation probes comprising a base sequence cleavably linked to a mass label and uses thereof | |
WO2004069184A3 (en) | Methods for treating, preventing and detecting helicobacter infection | |
NL1014361A1 (nl) | Bevestigingsorgaan. | |
NO20006205D0 (no) | Morfin-6-glukuronidsyntese | |
ES1047984Y (es) | Corchete de ortodoncia. | |
PT1064265E (pt) | Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona | |
NL1012028A1 (nl) | Aminozuursequentie. | |
DE29806109U1 (de) | Rohling | |
TR199801514A3 (tr) | N-Piruvil-L-Prolin üretimi için yöntem. | |
IT1317829B1 (it) | Processo per la preparazione di cefonicid per via enzimatica. | |
IT1311584B1 (it) | Metodo per la realizzazione di calzature, e calzature ottenute contale metodo. | |
ITSP980008A0 (it) | Foraunghie. | |
NO20040693L (no) | Fermenteringsmetode. | |
IT1311574B1 (it) | Chiodo endomidollare per omero. | |
ITMI991227A0 (it) | Apparecchio emettitore di gas anionico | |
ES1044588Y (es) | Diana magnetica. | |
IT1311346B1 (it) | Macchina per spaccare legna da ardere. | |
ES1041310Y (es) | Depresor lingual. | |
BR9705788B1 (pt) | macaco pneumático. | |
AU2001281828A1 (en) | Disubstituted 1,7-guanines | |
ES1041336Y (es) | Expositor de botellas, transformabable. | |
IT245874Y1 (it) | Sostegno-espositore per calzature. |